Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Evaluation of an educational intervention on the standard of neonatal resuscitation: orotracheal versus nasotracheal intubation].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2009
Same author

[Correct procedure in the presence of a fetal goiter associated with hypothyroidism. Observations from three cases].

Gynecologie, obstetrique & fertilite·2006
Same author

Minimum effective dose of midazolam for sedation of mechanically ventilated neonates.

Journal of clinical pharmacy and therapeutics·2005
Same author

[Computerized physician order entry softwares for pediatric units].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2005
Same author

[Oxygen therapy in the neonatal period].

Journal de gynecologie, obstetrique et biologie de la reproduction·2005
Same author

Benefit of antenatal glucocorticoids according to the cause of very premature birth.

Archives of disease in childhood. Fetal and neonatal edition·2004

Related Experiment Video

Updated: Jul 10, 2026

Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

[Medication errors in neonatology: a review].

R Lenclen1

  • 1Unité de Réanimation Néonatale, Centre hospitalier Poissy/Saint-Germain-en-Laye, 10, rue du champ Gaillard, 78300 Poissy, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|October 27, 2007
PubMed
Summary
This summary is machine-generated.

Medication errors are common, preventable adverse events, especially in neonates. Improving medication safety requires analyzing system errors and enhancing staff awareness in neonatal intensive care units.

More Related Videos

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

Related Experiment Videos

Last Updated: Jul 10, 2026

Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

Area of Science:

  • Medical Safety
  • Neonatal Care
  • Pharmacology

Background:

  • Medication errors are the most frequent medical errors, leading to preventable adverse events.
  • Neonates face a higher risk of medication errors compared to older populations.
  • Errors can occur at any stage: ordering, dispensing, and administration.

Purpose of the Study:

  • To highlight the prevalence and impact of medication errors in healthcare.
  • To emphasize the heightened vulnerability of neonates to medication errors.
  • To identify key areas for intervention to reduce adverse drug events.

Main Methods:

  • Analysis of reported medication errors across different stages of the medication process.
  • Review of factors contributing to drug errors, including human and system-based causes.
  • Examination of detection methods influencing reported error frequencies.

Main Results:

  • Medication errors are a leading cause of adverse events, with most being preventable.
  • Neonates are disproportionately affected by medication errors.
  • System analysis reveals that both human and system errors contribute to drug errors.

Conclusions:

  • Preventive strategies for medication errors necessitate a thorough system analysis.
  • Interventions in neonatal intensive care units should prioritize staff awareness and the medication administration process.
  • Reducing medication-related adverse events requires a focus on system improvements and personnel education.